MARKET

ATRS

ATRS

Antares Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.620
-0.020
-0.55%
After Hours: 3.690 +0.07 +1.93% 16:10 09/19 EDT
OPEN
3.650
PREV CLOSE
3.640
HIGH
3.790
LOW
3.550
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
3.960
52 WEEK LOW
2.530
MARKET CAP
590.28M
P/E (TTM)
-166.0550
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATRS News

  • Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference
  • GlobeNewswire.2d ago
  • Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet?
  • Simply Wall St..09/11 16:50
  • Antares Pharma Has Been Awarded A $8.3M Supply Contract From The Department Of Veterans Affairs
  • Benzinga.09/10 14:50
  • Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack
  • MarketWatch.08/20 13:09

More

Industry

Medical Equipment, Supplies & Distribution
+0.13%
Healthcare Equipment & Supplies
+0.21%

Hot Stocks

Name
Price
%Change

About ATRS

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
More

Webull offers Antares Pharma Inc (ATRS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.